Related Experiment Video
Updated: Apr 29, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration
Gang Cen1, Hong-Hua Ding, Bin Liu
1Department of General Surgery, The First People's Hospital Affiliated to Shanghai JiaoTong University, Shanghai, 200080, People's Republic of China.
Abstract:
Cortactin, an actin-interacting protein, is implicated in cytoskeletal architecture and often amplified in several types of cancer including gastric adenocarcinomas. Downregulation of cortactin decreases cell migration and invasion. However, how to regulate cortactin in gastric cancer remains largely unknown. Here, we report that FBXL5 interacts with and targets cortactin for ubiquitylation and subsequent proteasomal degradation. Furthermore, we showed that FBXL5-induced cortactin degradation is mediated by extracellular regulated signal kinase (ERK). Serine phosphorylation sites mutant, cortactinS405A/S418A, prevent FBXL5-induced cortactin degradation. Moreover, CortactinS405A/S418A exhibited stronger effects in promoting gastric cancer cell migration when compared to wild-type cortactin. Taken together, our data suggested a novel molecular mechanism for the negative regulation of cortactin by FBXL5 in gastric cancer cells migration.
Insights
FBXL5 targets cortactin for degradation in gastric cancer, inhibiting cell migration. This process is regulated by extracellular signal-regulated kinase (ERK) and cortactin phosphorylation.
Area of Science:
- Molecular biology
- Cancer research
- Cell biology
Background:
- Cortactin is an actin-interacting protein crucial for cytoskeletal dynamics.
- Cortactin amplification is observed in various cancers, including gastric adenocarcinomas.
- Reduced cortactin levels impede cancer cell migration and invasion.
Purpose of the Study:
- To investigate the regulatory mechanisms of cortactin in gastric cancer.
- To identify proteins that interact with and degrade cortactin.
- To elucidate the role of FBXL5 in cortactin regulation and its impact on gastric cancer cell migration.
Main Methods:
- Co-immunoprecipitation assays to identify protein interactions.
- Ubiquitylation assays to assess protein degradation pathways.
- Western blotting to detect protein levels and phosphorylation status.
- Site-directed mutagenesis to study specific phosphorylation sites (S405/S418) on cortactin.
- Cell migration assays to evaluate the functional impact of cortactin regulation.
Main Results:
- FBXL5 directly interacts with cortactin and targets it for ubiquitylation and proteasomal degradation.
- Extracellular signal-regulated kinase (ERK) mediates FBXL5-induced cortactin degradation.
- Mutating serine phosphorylation sites (S405/S418) on cortactin prevents FBXL5-mediated degradation.
- The phosphorylation-resistant cortactin mutant (cortactinS405A/S418A) enhances gastric cancer cell migration more than wild-type cortactin.
Conclusions:
- FBXL5 acts as a negative regulator of cortactin in gastric cancer cells.
- The FBXL5-ERK-cortactin axis represents a novel mechanism controlling cortactin stability and gastric cancer cell migration.
- Targeting the FBXL5-mediated degradation pathway could offer therapeutic strategies for gastric cancer.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Mitogens and the Cell Cycle

